We are live on ! Find out more
TXG icon

10x Genomics
TXG

85 hedge funds and large institutions have $2.35B invested in 10x Genomics in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more call options, than puts

Call options by funds: $5.9M | Put options by funds: $2.68M

109% more capital invested

Capital invested by funds: $1.13B → $2.35B (+$1.22B)

37% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 19

33.37% more ownership

Funds ownership: 113.98% → 147.35% (+33%)

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

4% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 27

8% less funds holding

Funds holding: 92 → 85 (-7)

Holders
85
Holders Change
-7
Holders Change %
-7.61%
% of All Funds
1.67%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.1%
New
26
Increased
26
Reduced
19
Closed
27
Calls
$5.9M
Puts
$2.68M
Net Calls
+$3.22M
Net Calls Change
+$3.22M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$40.9M
2
Morgan Stanley
Morgan Stanley
New York
+$38.1M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.2M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$19M
5
CS
Credit Suisse
Switzerland
+$12.1M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$29.9M
2
BlackRock
BlackRock
New York
-$27M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.56M
4
Victory Capital Management
Victory Capital Management
Texas
-$6.42M
5
Citadel Advisors
Citadel Advisors
Florida
-$4.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
51
Parametric Portfolio Associates
Washington
$1.3M -$57.9K -963 -5%
Ameriprise
52
Ameriprise
Minnesota
$1.28M +$366K +6,086 +57%
Schroder Investment Management Group
53
Schroder Investment Management Group
United Kingdom
$1.23M -$232K -3,865 -19%
OAM
54
Oxford Asset Management
United Kingdom
$911K -$4.85M -80,647 -87%
ZP
55
Zimmer Partners
New York
$763K – – –
TD Asset Management
56
TD Asset Management
Ontario, Canada
$735K -$166K -2,763 -22%
Wellington Management Group
57
Wellington Management Group
Massachusetts
$699K -$4M -66,458 -88%
Group One Trading
58
Group One Trading
Illinois
$576K +$454K +7,550 New
SPM
59
Symmetry Peak Management
Pennsylvania
$572K +$451K +7,500 New
Legal & General Group
60
Legal & General Group
United Kingdom
$532K +$90.2K +1,500 +27%
Deutsche Bank
61
Deutsche Bank
Germany
$453K – – –
TRCT
62
Tower Research Capital (TRC)
New York
$401K +$18.7K +311 +6%
RI
63
RTW Investments
New York
$381K – – –
State Street
64
State Street
Massachusetts
$358K +$283K +4,700 New
Susquehanna International Group
65
Susquehanna International Group
Pennsylvania
$338K -$360K -5,980 -57%
BM
66
Brandywine Managers
Delaware
$328K – – –
MCP
67
Mirador Capital Partners
California
$328K +$259K +4,300 New
D.E. Shaw & Co
68
D.E. Shaw & Co
New York
$305K +$241K +4,003 New
TSS
69
Two Sigma Securities
New York
$297K +$234K +3,895 New
Royal Bank of Canada
70
Royal Bank of Canada
Ontario, Canada
$283K +$218K +3,626 +4,369%
CIBC Asset Management
71
CIBC Asset Management
Ontario, Canada
$261K +$206K +3,425 New
CSS
72
Cubist Systematic Strategies
Connecticut
$249K +$125K +2,087 +177%
Stifel Financial
73
Stifel Financial
Missouri
$207K +$163K +2,709 New
Bank of America
74
Bank of America
North Carolina
$161K +$122K +2,037 +2,716%
IA
75
IFP Advisors
Florida
$47K +$36.1K +600 New
1 2
3
4 5

TXG Hedge Fund Activity: Q4 2019 in Review

85 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in 10x Genomics (TXG) for Q4 2019, worth a combined $2.35B — up 109% from $1.13B a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of TXG and 26 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 26 added.

The largest buyer was AllianceBernstein, adding an estimated $40.9M. The largest seller was T. Rowe Price Associates, cutting an estimated $29.9M.

  • 85 institutional investors held 10x Genomics (TXG) as of Q4 2019, down from 92 in Q3 2019.
  • Funds reported $2.35B of 10x Genomics stock for Q4 2019, up 109% quarter-over-quarter.
  • 26 funds opened new 10x Genomics positions in Q4 2019 and 27 closed out, a net change of -1 holder.
  • The largest 10x Genomics buyer in Q4 2019 was AllianceBernstein, an estimated $40.9M added.
  • The largest 10x Genomics seller in Q4 2019 was T. Rowe Price Associates, an estimated $29.9M sold.

Based on aggregated 13F filings for Q4 2019.